COMPANY PROFILE

Abyrx

Explore full profile

Specialty biosurgical products for use during surgical procedures

Stamford, United StatesFounded 2013Biotech & Life Sciences

Valuation $50–100M Last recorded · 2016

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Abyrx

Abyrx is a medical device company that develops and manufactures biomaterials and therapeutic devices for surgical procedures. The company's product portfolio includes resorbable hemostatic bone putties, such as HEMASORB and Montage, which are used to control bleeding from bone surfaces.

The company's business model is focused on developing and commercializing products for the orthopedic and cardiothoracic surgery markets. Abyrx's products are used by surgeons in hospitals and other healthcare facilities. The company generates revenue through the sale of its products to distributors and directly to healthcare providers.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2013
Headquarters: Stamford, United States
Employees: 20
Open positions: None listed
Dealroom signal: 77.3/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Investment activity: 1 company, latest Nov 2025
Capital deployed: —
Preferred round: MERGER
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
MERGER✓Other financing	Nov 2025	$0	—	Kairuku	↗
EARLY VC✓Equity / VC	Dec 2016	$10M	$40M	BB Biotech Ventures · Canaan	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Abyrx website traffic

Latest recorded traffic for Abyrx is 3.7K monthly website visits, up 117.6% over the last three months. Abyrx's team grew 25% over the past year.

Latest monthly visits3.7K 3-month web change+117.6% 1-year team growth+25%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VMVelico MedicalImproving The Availability, Delivery And Economics Of Plasma & Platelets For Transfusion	Beverly, United States	Operational	53	$19M	$76M
WMWindgap MedicalA biotech company that manufactures medical devices	Watertown, United States	Operational
UMUptake MedicalInnovative technologies for the treatment of lung diseases	Seattle, United States	Acquired
NMNano Precision MedicalDevelops novel miniaturized subdermal implants	Emeryville, United States	Operational
INInnoVeinInnoVein is revolutionizing vein care with an implantable valve	San Carlos, United States	Closed
TBTheranica Bio-ElectronicsBrings electrical neuromodulation therapy to a new level	Netanya, Israel	Operational
CICEGA InnovationsCEGA Innovations engineers enhanced, affordable technologies that improve patient care and provide a safer workplace for all medical professionals.	Sioux Falls, United States	Operational
GTGlyGenix TherapeuticsBiotech & Life Sciences	Woodbridge, United States	Operational